Geron (GERN)
(Real Time Quote from BATS)
$1.34 USD
+0.14 (11.67%)
Updated Aug 6, 2025 03:20 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GERN 1.34 +0.14(11.67%)
Will GERN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GERN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GERN
Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates
Incyte (INCY) Surpasses Q2 Earnings and Revenue Estimates
GERN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Geron (GERN) Reports Q1 Loss, Lags Revenue Estimates
Geron (GERN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Geron (GERN) Reports Q4 Loss, Tops Revenue Estimates
Other News for GERN
Geron appoints Harout Semerjian as CEO
Geron (GERN) Appoints New CEO, Harout Semerjian
Geron taps Harout Semerjian as CEO
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Geron reports Q2 EPS (2c), consensus (3c)